Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool (DePRO)

Bayer

Status: Completed

Conditions: Diabetes Mellitus, Type 2

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT04383041

21318

Details and patient eligibility

About

In this study researchers want to gain more information on patients who are treated with Metformin for their Type 2 Diabetes. Adult female and male patients with a prescription of a Metformin containing drug will be invited to the study in a public pharmacy after the decision for treatment with Metformin has been made by the treating physician. The pharmacist will provide interested participants access to a special phone App and participants are asked to complete via this phone App a questionnaire on their health situation with special focus on their Type 2 Diabetes. This includes questions on complications and self-care activities in relation to their diabetes, questions on quality of life and health history. There will be no extra visit to the treating doctor or a pharmacy. The study is aiming to have the questionnaire completed by 300 participants.

Enrollment: 32 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult female or male patient
• Valid prescription for a Metformin containing drug approved in Germany
• Decision to initiate treatment with Metformin was made by the treating physician as part of the routine treatment practice
• Signed informed consent

Exclusion criteria

• Not applicable

Trial design

32 participants in 1 patient group

Patients with Type 2 Diabetes

Description:

Patients with Metformin containing prescription drugs will be eligible for participation and consecutively invited to study participation in their pharmacy.

Treatment:

Other: No intervention